Cellular Biomedicine Group Inc

CBMG

$19.75

0.0% (1 year change)

Avg closing price

Price range

Market Cap

$0

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$0.00 - $0.00

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $0
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return 0.0%
52-Week High $0.00
52-Week Low $0.00
Beta 0.0
Outstanding Shares 19.5 Million
Avg 30 Day Volume 0

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger

ROCKVILLE, Md. and SHANGHAI , Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG ) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug develop...

Benzinga Benzinga, 4 months ago
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting

Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting

GAITHERSBURG, Md. and SHANGHAI, Dec. 4, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of im...

PR Newswire PR Newswire, 5 months ago
Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights

Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights

GAITHERSBURG, Md. and SHANGHAI, Nov. 9, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of im...

PR Newswire PR Newswire, 6 months ago